Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

An Overview of Pediatric, Noninfectious Uveitis

Joseph McDonald, MD, Virginia Miraldi Utz, MD, & Sheila T. Angeles-Han, MD, MS  |  Issue: October 2018  |  

Dr. Utz reports no support or research specific to this topic, but serves on the Pediatric Advisory Board for Spark Therapeutics, has received royalties for a textbook from Springer Publishing and has served as an unpaid investigator for Retrophin.

Dr. Angeles-Han developed the Effects of Youngsters’ Eyesight on Quality of Life (EYE-Q) tool, which has a license through Emory University. No royalties have been received by any of the authors. She is supported by Award No. K23EY021760 from the National Eye Institute, a grant from the Rheumatology Research Foundation and the CCHMC Research Innovation and Pilot Award.

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Thorne JE, Suhler E, Skup M, et al. Prevalence of noninfectious uveitis in the United States: A claims-based analysis. JAMA Ophthalmol. 2016 Nov 1;134(11):1237–1245.
  2. Acharya NR, Tham VM, Esterberg E, et al. Incidence and prevalence of uveitis: Results from the Pacific Ocular Inflammation Study. JAMA Ophthalmol. 2013 Nov;131(11):1405–1412.
  3. Gregory AC, Kempen JH, Daniel E, et al. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: The systemic immunosuppressive therapy for eye diseases study. Ophthalmology. 2013 Jan;120(1):186–192.
  4. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California: The Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004 Mar;111(3):491–500.
  5. Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009 Aug;116(8):1544–1551.
  6. Holland GN, Stiehm ER. Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol. 2003 Jun;135(6):867–878.
  7. Edelsten C, Reddy MA, Stanford MR, et al. Visual loss associated with pediatric uveitis in english primary and referral centers. Am J Ophthalmol. 2003 May;135(5):676–680.
  8. Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004 Dec;111(12):2299–2306.
  9. Nordal E, Rypdal V, Christoffersen T, et al. Incidence and predictors of uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study. Pediatr Rheumatol Online J. 2017 Aug;15(1):66.
  10. BenEzra D, Cohen E, Behar-Cohen F. Uveitis and juvenile idiopathic arthritis: A cohort study. Clin Ophthalmol. 2007 Dec;1(4):513–518.
  11. Kanski JJ. Juvenile arthritis and uveitis. Surv Ophthalmol. 1990 Jan–Feb;34(4):253–267.
  12. Sabri K, Saurenmann RK, Silverman ED, et al. Course, complications and outcome of juvenile arthritis-related uveitis. J AAPOS. 2008 Dec;12(6):539–545.
  13. Kump LI, Cervantes-Castañeda RA, Androudi SN, et al. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005 Jul;112(7):1287–1292.
  14. de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003 Jul;87(7):879–884.
  15. Kanski JJ, Shun-Shin GA. Systemic uveitis syndromes in childhood: An analysis of 340 cases. Ophthalmology. 1984 Oct;91(10):1247–1252.
  16. Angeles-Han ST, McCracken C, Yeh S, et al. Characteristics of a cohort of children with juvenile idiopathic arthritis and JIA-associated uveitis. Pediatr Rheumatol Online J. 2015 Jun 2;13:19.
  17. Holland GN, Denove CS, Yu F. Chronic anterior uveitis in children: Clinical characteristics and complications. Am J Ophthalmol. 2009 Apr;147(4):667–678.
  18. Woreta F, Thorne JE, Jabs DA, et al. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007 Apr;143(4):647–655.
  19. American Academy of Pediatrics section on rheumatology and section on ophthalmology: Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 1993 Aug;92(2):295–296.
  20. Cassidy J, Kivlin J, Lindsley C, et al. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 2006 May;117(5):1843–1845.
  21. Heiligenhaus A, Niewerth M, Ganser G, et al. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: Suggested modification of the current screening guidelines. Rheumatology (Oxford). 2007 Jun;46(6):1015–1019.
  22. Chia A, Lee V, Graham EM, et al. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol. 2003 Jun;135(6):757–762.
  23. Edelsten C, Lee V, Bentley CR, et al. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002 Jan;86(1):51–56.
  24. Miller ML, Fraser PA, Jackson JM, et al. Inherited predisposition to iridocyclitis with juvenile rheumatoid arthritis: Selectivity among HLA-DR5 haplotypes. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3539–3542.
  25. Malagon C, Van Kerckhove C, Giannini EH, et al. The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: Outcome in immunogenetically characterized patients. J Rheumatol. 1992 Jan;19(1):160–163.
  26. Melin-Aldana H, Giannini EH, Taylor J, et al. Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis. J Pediatr. 1992 Jul;121(1):56–60.
  27. Giannini EH, Malagon CN, Van Kerckhove C, et al. Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis. J Rheumatol. 1991 Sep;18(9):1394–1397.
  28. Glass D, Litvin D, Wallace K, et al. Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis and antinuclear antibody. J Clin Invest. 1980 Sep;66(3):426–429.
  29. Angeles-Han ST, McCracken C, Yeh S, et al. HLA associations in a cohort of children with juvenile idiopathic arthritis with and without uveitis. Invest Ophthalmol Vis Sci. 2015 Sep;56(10):6043–6048.
  30. Haasnoot AJ, van Tent-Hoeve M, Wulffraat NM, et al. Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis. Am J Ophthalmol. 2015 Feb;159(2):372–377.
  31. Haasnoot AJ, Kuiper JJ, Hiddingh S, et al. Ocular fluid analysis in children reveals interleukin-29/interferon-lambda1 as a biomarker for juvenile idiopathic arthritis associated uveitis. Arthritis Rheumatol. 2016 Jul;68(7):1769–1779.
  32. Kalinina AV, de Boer JH, Byers HL, et al. Intraocular biomarker identification in uveitis associated with juvenile idiopathic arthritis. Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3709–3720.
  33. Sijssens KM, Rijkers GT, Rothova A, et al. Distinct cytokine patterns in the aqueous humor of children, adolescents and adults with uveitis. Ocul Immunol Inflamm. 2008 Sep–Oct;16(5):211–216.
  34. Walscheid K, Heiligenhaus A, Holzinger D, et al. Elevated S100A8/A9 and S100A12 serum levels reflect intraocular inflammation in juvenile idiopathic arthritis-associated uveitis: Results from a pilot study. Invest Ophthalmol Vis Sci. 2015 Dec;56(13):7653–7660.
  35. Angeles-Han ST, Pelajo CF, Vogler LB, et al. Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. J Rheumatol. 2013 Dec;40(12):2088–2096.
  36. Angeles-Han ST, McCracken C, Yeh S, et al. The association of race with childhood uveitis. Am J Ophthalmol. 2015 Nov;160(5):919–928.
  37. Saurenmann RK, Levin AV, Feldman BM, et al. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum. 2010 Jun;62(6):1824–1828.
  38. Chalom EC, Goldsmith DP, Koehler MA, et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol. 1997 Oct;24(10):2031–2034.
  39. Dana MR, Merayo-Lloves J, Schaumberg DA, et al. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997 Feb;104(2):236–244.
  40. Cabral DA, Petty RE, Malleson PN, et al. Visual prognosis in children with chronic anterior uveitis and arthritis. J Rheumatol. 1994 Dec;21(12):2370–2375.
  41. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3):509–516.
  42. Smith JR, Rosenbaum JT. Management of uveitis: A rheumatologic perspective. Arthritis Rheum. 2002 Feb;46(2):309–318.
  43. Venkatesh P, Macrae M, Fleck BW. Lothian combined paediatric ophthalmology and rheumatology service. Br J Ophthalmol. 2006 Dec;90(12):1549–1550.
  44. Angeles-Han ST. Quality-of-life metrics in pediatric uveitis. Int Ophthalmol Clin. 2015 Spring;55(2):93–101.
  45. Angeles-Han ST, Griffin KW, Harrison MJ, et al. Development of a vision-related quality of life instrument for children ages 8–18 years for use in juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken). 2011 Sep;63(9):1254–1261.
  46. Angeles-Han ST, Yeh S, McCracken C, et al. Using the effects of youngsters’ eyesight on quality of life questionnaire to measure visual outcomes in children with uveitis. Arthritis Care Res (Hoboken). 2015 Nov;67(11):1513–1520.
  47. Angeles-Han ST, Griffin KW, Lehman TJ, et al. The importance of visual function in the quality of life of children with uveitis. J AAPOS. 2010 Apr;14(2):163–168.

Related Articles

    Watch Those Eyes

    What you need to know about Uveitis in Rheumatic Diseases

    ARZTSAMUI / shutterstock.com

    Uveitis: A Brief Primer for the Rheumatologist

    Uveitis is an umbrella term for intraocular inflammatory diseases that can lead to vision loss. It’s not just a concern for ophthalmologists. Uveitis occurs in approximately 2–5% of patients with inflammatory bowel disease, 6–9% of patients with psoriatic arthritis and 25% of patients with reactive arthritis. The prevalence may be as high as 33% in…

    New Guideline Recommends Frequent Monitoring & Collaboration for JIA-Associated Uveitis Management

    As soon as pediatric patients are diagnosed with juvenile idiopathic arthritis (JIA), they should also be screened for uveitis, says ophthalmologist Gary Holland, MD. Otherwise, the University of California, Los Angeles, provider says, “Kids who are diagnosed with JIA may not come to an ophthalmologist until they have vision-limiting complications.” Uveitis is the most common…

    Oksana Kuzmina/shutterstock.comx

    Environmental Factors in Pediatric Systemic Autoimmune Diseases

    Systemic autoimmune diseases are thought to result from immune dysregulation in genetically susceptible individuals who were exposed to environmental risk factors. Many studies have identified genetic risk factors for these diseases, but concordance rates among monozygotic twins are 25–40%, suggesting that nonheritable environmental factors play a more prominent role.1,2 Through carefully conducted epidemiologic and other…